caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1912287764

Matthew Sigafus

PRACTICEUNIVERSITY OF PENN-PA TRAUMASee all providers at this practice →
Nurse PractitionerPhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
621
Beneficiaries
—
Total drug cost
$99K
Distinct drugs
15
Brand share
17.2%
Top prescribed drugs
Tacrolimus250 claims
Ursodiol65 claims
Mycophenolate Mofetil48 claims
Sulfamethoxazole/Trimethoprim46 claims
Prednisone43 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$22
Payment records
1
By payment type
Food and Beverage$22
REFERRAL NETWORK

Where Matthew Sigafus's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
27140
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1663
Jennifer Deuel
Physician Assistant · Philadelphia, PA
1643
MAKAR, GEORGE1448
KNIGHT, ELIZABETH1229
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.